Endothelial dysfunction through genetic deletion or inhibition of the G protein-coupled receptor Mas: a new target to improve endothelial function - PubMed (original) (raw)
Endothelial dysfunction through genetic deletion or inhibition of the G protein-coupled receptor Mas: a new target to improve endothelial function
Concepcion Peiró et al. J Hypertens. 2007 Dec.
Abstract
Background: Endothelial dysfunction is an initial step in the pathogenesis of cardiovascular diseases. Since we previously identified the G protein-coupled receptor Mas as a receptor for angiotensin (Ang)-(1-7), a heptapeptide with endothelium-dependent vasorelaxant properties, we investigated whether alterations on the Ang-(1-7)/Mas axis alter endothelial function.
Results: Ang-(1-7)-mediated relaxation of murine wild-type mesenteric arteries was equally impaired in both wild-type arteries pretreated with the Ang-(1-7) receptor blocker, A779, and arteries isolated from Mas-deficient mice. Importantly, the response to the endothelium-dependent vasorelaxant, bradykinin (BK), and acetylcholine (ACh) effects were comparably inhibited, while endothelium-independent vessel relaxation by sodium nitroprusside was unaltered in these vessels. Hypothesizing endothelial dysfunction, we proved the in-vivo relevance of the ex-vivo findings investigating mesenteric properties after 1 week of minipump infusion of A779 in wild-type mice. Both BK- and ACh-induced relaxation were significantly impaired in wild-type vessels of pretreated animals. A779-induced impairment of endothelial function was confirmed in vitro, since BK-mediated nitric oxide (NO) release was increased by Ang-(1-7) and blunted by A779 pretreatment in primary human endothelial cell cultures.
Conclusions: Our data highlight a pivotal role for the receptor Mas in preserving normal vascular relaxation. Consequently, Mas agonists arise as a promising tool in the treatment of cardiovascular diseases characterized by endothelial dysfunction.
Similar articles
- Complete blockade of the vasorelaxant effects of angiotensin-(1-7) and bradykinin in murine microvessels by antagonists of the receptor Mas.
Peiró C, Vallejo S, Gembardt F, Palacios E, Novella S, Azcutia V, Rodríguez-Mañas L, Hermenegildo C, Sánchez-Ferrer CF, Walther T. Peiró C, et al. J Physiol. 2013 May 1;591(9):2275-85. doi: 10.1113/jphysiol.2013.251413. Epub 2013 Mar 4. J Physiol. 2013. PMID: 23459756 Free PMC article. - Angiotensin-(1-7) Selectively Induces Relaxation and Modulates Endothelium-Dependent Dilation in Mesenteric Arteries of Salt-Fed Rats.
Raffai G, Lombard JH. Raffai G, et al. J Vasc Res. 2016;53(1-2):105-118. doi: 10.1159/000448714. Epub 2016 Sep 28. J Vasc Res. 2016. PMID: 27676088 Free PMC article. - Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice.
Tesanovic S, Vinh A, Gaspari TA, Casley D, Widdop RE. Tesanovic S, et al. Arterioscler Thromb Vasc Biol. 2010 Aug;30(8):1606-13. doi: 10.1161/ATVBAHA.110.204453. Epub 2010 May 6. Arterioscler Thromb Vasc Biol. 2010. PMID: 20448208 - Angiotensin (1-7) and Alamandine: Similarities and differences.
Qaradakhi T, Apostolopoulos V, Zulli A. Qaradakhi T, et al. Pharmacol Res. 2016 Sep;111:820-826. doi: 10.1016/j.phrs.2016.07.025. Epub 2016 Jul 22. Pharmacol Res. 2016. PMID: 27456244 Review. - Angiotensin-(1-7): a novel vasodilator of the coronary circulation.
Brosnihan KB, Li P, Tallant EA, Ferrario CM. Brosnihan KB, et al. Biol Res. 1998;31(3):227-34. Biol Res. 1998. PMID: 9830510 Review.
Cited by
- Angiotensin-(1-7) improves oxygenation, while reducing cellular infiltrate and fibrosis in experimental Acute Respiratory Distress Syndrome.
Zambelli V, Bellani G, Borsa R, Pozzi F, Grassi A, Scanziani M, Castiglioni V, Masson S, Decio A, Laffey JG, Latini R, Pesenti A. Zambelli V, et al. Intensive Care Med Exp. 2015 Dec;3(1):44. doi: 10.1186/s40635-015-0044-3. Epub 2015 Feb 27. Intensive Care Med Exp. 2015. PMID: 26215809 Free PMC article. - Differential mechanisms of ang (1-7)-mediated vasodepressor effect in adult and aged candesartan-treated rats.
Bosnyak S, Widdop RE, Denton KM, Jones ES. Bosnyak S, et al. Int J Hypertens. 2012;2012:192567. doi: 10.1155/2012/192567. Epub 2011 Nov 30. Int J Hypertens. 2012. PMID: 22187625 Free PMC article. - Targeting Neprilysin (NEP) pathways: A potential new hope to defeat COVID-19 ghost.
Mohammed El Tabaa M, Mohammed El Tabaa M. Mohammed El Tabaa M, et al. Biochem Pharmacol. 2020 Aug;178:114057. doi: 10.1016/j.bcp.2020.114057. Epub 2020 May 27. Biochem Pharmacol. 2020. PMID: 32470547 Free PMC article. Review. - Complete blockade of the vasorelaxant effects of angiotensin-(1-7) and bradykinin in murine microvessels by antagonists of the receptor Mas.
Peiró C, Vallejo S, Gembardt F, Palacios E, Novella S, Azcutia V, Rodríguez-Mañas L, Hermenegildo C, Sánchez-Ferrer CF, Walther T. Peiró C, et al. J Physiol. 2013 May 1;591(9):2275-85. doi: 10.1113/jphysiol.2013.251413. Epub 2013 Mar 4. J Physiol. 2013. PMID: 23459756 Free PMC article. - A systematic review to investigate whether Angiotensin-(1-7) is a promising therapeutic target in human heart failure.
Lee VC, Lloyd EN, Dearden HC, Wong K. Lee VC, et al. Int J Pept. 2013;2013:260346. doi: 10.1155/2013/260346. Epub 2013 Dec 12. Int J Pept. 2013. PMID: 24454410 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous